Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System

Published:2022 Issue:16 Volume:37 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Chung Soo Jie¹²^ORCID,Byeon Sun-ju³^ORCID,Choi Jeong-Hee¹²^ORCID

Affiliation:

1. Department of Pulmonology and Allergy, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.

2. Allergy and Clinical Immunology Research Center, Hallym University College of Medicine, Chuncheon, Korea.

3. Department of Pathology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.

Funder

Ministry of Food and Drug Safety

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2022.37.e128

Reference23 articles.

1. Global tuberculosis report 2020. Updated 2020. Accessed March 1, 2021. https://www.who.int/publications/i/item/9789240013131

2. Evaluación de las reacciones adversas de los antituberculosos en pacientes hospitalizados

3. Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis

4. Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulators targeting protein-protein interactions in Mycobacterium tuberculosis;Microbiological Research;2024-07

2. Safety of pyrazinamide in elderly patients with tuberculosis in Japan: A nationwide cohort study;Respirology;2024-05-21

3. Drug-induced hypothyroidism in tuberculosis;Expert Review of Endocrinology & Metabolism;2024-01-23

4. Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review;Revista da Sociedade Brasileira de Medicina Tropical;2024

5. Application of the Hollow-Fiber Infection Model to Personalized Precision Dosing of Isoniazid in a Clinical Setting;Journal of Korean Medical Science;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3